Clinical evaluation of cefroxadine in the field of obstetrics and gynecology
Uchida, S.; Hayashi, H.; Tominaga, M.; Kohno, K.; Matsunaga, M.; Kudo, S.; Kawamura, R.
Japanese Journal of Antibiotics 36(9): 2549-2555
1983
ISSN/ISBN: 0368-2781 PMID: 6655869 Document Number: 199401
Cefroxadine (CXD), an oral cephalosporin antibiotic was studied in the field of obstetrics and gynecology and the following results were obtained. CXD was orally given to 22 cases at daily dose of 1,500 mg 3 times a day. CXD administration was given to 22 cases in all; 4 with cervicitis, 6 with endometritis, 2 with puerperal fever, 4 with bartholinitis, 5 with adnexitis and 1 with vulvitis, respectively. Overall efficacy rate was 77.3% (17/22) (excellent 4, good 13, fair 5). As for side effects, a slight diarrhea was observed. CXD was considered to be a useful antibiotic in the field of obstetrics and gynecology by above the results.